US · LIMN
Liminatus Pharma, Inc. Class A Common Stock
- Sector
- Healthcare · Biotechnology
- Headquarters
- La Palma, CA 90623
- Website
- liminatuspharma.com
Price · as of 2026-07-02
$0.14
Market cap 4.39M
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 |
USD millions
Line items
USD millions
Line items
USD millions
Line items
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | Model Valuation | Core Valuation | Growth | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| LIMN | Liminatus Pharma, Inc. Cl… | $0.14 | 4.39M | — | — | — | — | — | — | — | — | — |
| ATHE | Alterity Therapeutics Lim… | $4.08 | 69.12M | +450% | -29% | — | — | -6.79 | 1.95 | 15.18 | -2.87 | 3532.00% |
| BTAI | BioXcel Therapeutics, Inc… | $1.26 | 38.91M | — | — | — | +27,326% | — | — | — | — | — |
| DYAI | Dyadic International, Inc… | $0.71 | 25.87M | — | — | — | +1,612% | — | — | — | — | — |
| EVAX | Evaxion Biotech A/S | $4.10 | 25.9M | — | — | — | — | — | — | — | — | — |
| GBIO | Generation Bio Co. | $5.34 | 35.98M | +46% | -60% | — | — | -0.27 | 0.41 | 1.78 | 0.76 | 23692.00% |
| JSPR | Jasper Therapeutics, Inc. | $0.89 | 14.47M | — | — | — | — | -1.10 | 1.27 | — | -0.11 | — |
| MURA | Mural Oncology plc | $2.04 | 35.38M | — | — | — | — | -0.48 | 0.44 | — | 0.60 | — |
| SABS | SAB Biotherapeutics, Inc. | $3.57 | 34.12M | +259% | -82% | — | +3,106% | -0.44 | 0.58 | 11.35 | 0.04 | -4094.00% |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $0.14) − 1 = — (DCF, example).